George Dudnik, 36, was initially told he had mumps after waking up at 3am with a swollen face in December 2023.

Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology ...

During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...

As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

FRANKFURT, March 9 (Reuters) - Europe should reduce its dependence on a small number of countries for vital drug supplies such as antibiotics and anaesthetics to boost the bloc's preparedness for ...

FLuID enables privacy-preserving knowledge sharing in drug discovery using knowledge distillation. The results show that the approach expands applicability domains and fosters collaboration across ...

About 1% to 2% of NSCLCs have the ROS1 mutation. The ROS1 mutation is similar to the ALK mutation. Some of the same drugs help treat both mutations. Targeted therapies for ROS1-positive lung ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon ...